Trial Profile
Planned phase IIb trial of RG 7128 in patients with hepatitis C genotype 2 or 3.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2011
Price :
$35
*
At a glance
- Drugs Mericitabine (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Feb 2011 Roche expects to initiate this study in the first half of 2011, according to a Pharmasset media release
- 06 Jan 2011 Roche expects to initiate this study in the first quarter of 2011, according to a Pharmasset media release
- 06 Jan 2011 Planned initiation date changed from 30 Jun 2010 to 1 Jan 2011.